Days Speakers Session Type Search
Full screen
List At A Glance
Speaker list
Categories Posters
List
List
Type
Saturday 18 May 7 sessions
    09:00 - 17:00 
    Pre-congress Courses
    12:00 - 20:00 
    REGISTRATION
    17:00 - 17:45 
    ECE 2019 Opening Ceremony
    L'Amphithéâtre
    17:45 - 18:15 
    Plenary: Geoffrey Harris Award Lecture
    L'Amphithéâtre
    Chairs: AJ van der Lely (The Netherlands) & Monica Marazuela (Spain)
    17:45
    GH1
    Translational research in pituitary disease
    Günter Stalla
    18:20 - 18:50 
    Plenary: European Journal of Endocrinology Award Lecture
    L'Amphithéâtre
    Chairs: Wiebke Arlt (UK) & AJ van der Lely (The Netherlands)
    18:20
    EJE1
    New approaches in the differential diagnosis of Diabetes insipidus
    Mirjam Christ-Crain (Basel, Switzerland)
    19:00 - 19:30 
    Plenary 1
    L'Amphithéâtre
    Chairs: Marta Korbonits (UK) & Sebastian Neggers (The Netherlands)
    19:00
    PL1
    Designing Cities and Homes as Exercise Machines: Helping endocrinologists to fight metabolic disease
    Avi Friedman
    19:30 - 20:45 
    Welcome Reception
    Exhibition area
Sunday 19 May 45 sessions
    07:00 - 18:00 
    REGISTRATION
    08:00 - 08:40 
    Meet The Expert 1: Diabetes, Obesity and Metabolism
    Forum 3
    Diabetes, Obesity and Metabolism
    08:00
    MTE1
    The road from flash and continuous glucose monitoring towards closed loop systems in diabetes
    Christophe Block
    08:00 - 08:40 
    Meet The Expert 2: Diabetes, Obesity and Metabolism
    Auditorium Lumière
    Diabetes, Obesity and Metabolism
    08:00
    MTE2
    Long-term endocrine-metabolic effects of bariatric surgery: do the benefits really outweigh the risks?
    Roberto Vettor
    08:00 - 08:40 
    Meet The Expert 3: Adrenal and Neuroendocrine Tumours
    Forum 2
    Adrenal and Neuroendocrine Tumours
    08:00
    MTE3
    The management of primary aldosteronism
    Andrzej Januszewicz
    08:00 - 08:40 
    Meet The Expert 4: Adrenal and Neuroendocrine Tumours
    Salle Gratte-Ciel 1+2+3
    Adrenal and Neuroendocrine Tumours
    08:00
    MTE4
    Management of a life-long disease in CAH
    Nicole Reisch (Munich, Germany)
    08:00 - 08:40 
    Meet The Expert 5: Thyroid
    L'Amphithéâtre
    Thyroid
    08:00
    MTE5
    Risk classification of thyroid nodules by ultrasound and indications for FNA
    Laurence Leenhardt
    08:00 - 08:40 
    Meet The Basic Scientist 1: Interdisciplinary Endocrinology
    Forum 1
    Interdisciplinary Endocrinology
    08:00
    MTBS1
    New tracers for PET in humans and rodents: Hopes, aims and current evidence
    Lars Gormsen
    08:00 - 08:45 
    Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
    Salon Prestige Gratte Ciel
    Chairs: AJ van der Lely (The Netherlands) & Andrea Giustina (Italy)
    PEM1
    08:00
    PEM1.1
    Introduction: Why Policy and Advocacy matters, also to endocrinology - Includes methodology, response, demographics
    Andrea Giustina
    08:05
    PEM1.2
    The clinical view of Endocrinology in Europe
    Jerome Bertherat (France)
    08:15
    PEM1.3
    The research view of Endocrinology in Europe
    Felix Beuschlein (Zürich, Switzerland)
    08:25
    PEM1.4
    The early-career perspective
    Anneke Beukel
    08:35
    PEM1.5
    Closing remarks and discussion
    Andrea Giustina
    08:50 - 09:20 
    Interview with the ESE President and President-Elect
    L'Amphithéâtre
    09:20 - 09:50 
    Plenary 2
    ENDORSED BY: EJE (European Journal of Endocrinology)
    L'Amphithéâtre
    Chairs: Manuel Tena-Sempere (Spain) & Csilla Krausz (Italy)
    PL2
    09:20
    PL2
    Genetic epidemiology of puberty timing and reproductive lifespan
    Ken Ong (Cambridge, United Kingdom)
    09:50 - 10:20 
    Tea & Coffee
    Exhibition area
    10:20 - 11:50 
    Symposium 1: Thyroid in cancer
    Forum 3
    Chairs: Barbara Jarzab (Poland) & Sophie Leboulleux (France)
    Thyroid
    10:20
    S1.1
    What is the value of molecular markers in nodules
    Laura Fugazzola
    10:50
    S1.2
    Iodine refractoriness in thyroid cells
    Chris McCabe (UK, Birmingham)
    11:20
    S1.3
    New paradigms in the treatment of low risk thyroid cancer
    Martin Schlumberger
    10:20 - 11:50 
    Symposium 2: Trends in Puberty
    Forum 2
    Chairs: Carlo Acerini (UK) & Vincent Prevot (France)
    Reproductive Endocrinology
    10:20
    S2.1
    Exploring the Epigenetic Landscape of Puberty
    Alejandro Lomniczi
    10:50
    S2.2
    Endocrine disruptors in puberty
    Anne-Simone Parent (Liège, Belgium))
    11:20
    S2.3
    Genetic basis in puberty
    Sasha Howard (London, UK)
    10:20 - 11:50 
    Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
    Salle Gratte-Ciel 1+2+3
    Chairs: Ashley Grossman (UK) & Gudmundur Johannsson (Sweden)
    Interdisciplinary Endocrinology
    10:20
    S3.1
    Circadian control of glucocorticoid function
    David Ray (Manchester, UK)
    10:50
    S3.2
    Fixing the Broken Clock in Adrenal Disorders
    Andrea Isidori
    11:20
    S3.3
    Light Up Your Sex Life!
    Takashi Yoshimura
    10:20 - 11:50 
    Symposium 4: Immunology and endocrinology
    ENDORSED BY: EC (Endocrine Connections)
    Forum 1
    Chairs: Sandra Pekic (Serbia) & Simon Pearce (UK)
    Interdisciplinary Endocrinology
    10:50
    S4.2
    Clinical: Immunotherapy and endocrine disease
    Maria Stelmachowska-Banas
    11:00
    S4.3
    Transitional: The diagnostic value of autoimmune antibodies in endocrine disorders
    Olle Kämpe
    11:20
    S4.1
    Basic: Immunotherapy and endocrine disease
    Patrizio Caturegli
    10:20 - 11:50 
    Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
    L'Amphithéâtre
    Chairs: Anton Luger (Austria) & Ioannis Androulakis (Greece)
    Diabetes, Obesity and Metabolism
    10:20
    S5.1
    Human gut microbiome: hopes, threats and promises
    Hubert Vidal
    10:50
    S5.2
    Fecal transplantation: Myth or reality
    Max Nieuwdorp
    11:20
    S5.3
    Targeted Microbiome Intervention for handling insulin resistance
    Matthias Laudes
    10:20 - 11:50 
    Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
    Auditorium Lumière
    Chairs: AJ van der Lely (The Netherlands) & Jenny Visser (The Netherlands) & Andre Lacroix (Canada)
    10:20
    SS1.1
    Obesity gives you cancer: the bigger picture!
    Jeff Holly
    10:50
    SS1.2
    Sleep Deficiency: A Pathway to Obesity
    Erin Hanlon
    11:20
    SS1.3
    Social economic impact of the globesity pandemic
    Felipe Casanueva
    10:20 - 11:50 
    Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
    Salon Prestige Gratte-Ciel
    Chairs: Niki Karavitaki (UK) & Chona Feliciano (UK)
    10:20
    NS1.1
    Overview of Immunotherapy: Indications and adverse effects
    Christelle Fouchardiere
    10:55
    NS1.2
    Immunotherapy-induced Endocrinopathies: Assessment, Management and Monitoring
    Daniel Morganstein
    11:30
    NS1.3
    The Role of the Endocrine Nurse in Managing Patients with Immunotherapy-induced Endocrinopathies
    Sherwin Criseno (Birmingham, UK)
    12:00 - 13:00 
    Controversies Session: Food addiction in humans: to be or not to be?
    L'Amphithéâtre
    Chairs: Uberto Pagotto (Italy) & Gatta-Cherifi Blandine (France)
    Interdisciplinary Endocrinology
    12:00
    C1.1
    Food addiction in humans: to be or not to be?
    Fernando Fernandez-Aranda
    12:00 - 13:00 
    ESE Council of Affiliated Societies Session
    Auditorium Lumiere
    Chairs: Djuro Macut (Serbia) & Bulent Yildiz (Turkey)
    12:00
    ECAS1.1
    Mapping Endocrinology in Europe - ECAS report
    Djuro Macut
    12:20
    ECAS1.2
    Centres of special interest - how could we move on?
    George Mastorakos
    12:40
    ECAS1.3
    3rd Early Career Clinical Endocrinologist session at EndoBridge 2019 - referring of a patient from primary care to the endocrinology unit
    Bulent Yildiz
    12:00 - 13:00 
    Oral Communications 1: Calcium and Bone
    Salle Gratte-Ciel 1+2+3
    Chairs: Lars Rejnmark (Denmark) & Peter Kamenicky (France)
    OC1
    12:00
    OC1.1
    Genetic testing for hereditary hyperparathyroidism in a large UK cohort
    Ruth Casey (Cambridge, United Kingdom)
    12:12
    OC1.2
    Urinary magnesium as predictor of nephrolithiasis in patients with asymptomatic primary hyperparathyroidism
    Federica Saponaro
    12:24
    OC1.3
    MENIN AND EZH2 ACTIVITIES MODULATE THE EXPRESSION OF THE LONG NON-CODING RNA HAR1B IN PARATHYROID TUMORS
    Sabrina Corbetta
    12:36
    OC1.4
    Risk of Sepsis, Respiratory Infections, and Kidney or Other Genitourinary (GU) Infections in Patients with Chronic Hypoparathyroidism (HypoPT): A Retrospective Cohort Study
    Kristina Chen
    12:48
    OC1.5
    Renal Function in 711 patients with Hypoparathyroidism during more than 4 years of therapy
    Heide Siggelkow
    12:00 - 13:00 
    Nurses Session 2: Meet the Nurse Expert
    Salon Prestige Gratte-Ciel
    Chairs: Sherwin Criseno (UK) & Janina Sauerwald (Germany)
    12:00
    MTNE1
    Nursing Approach To The Holistic Care of Patients with Intellectual Disability
    Ruth Northway
    12:00 - 13:00 
    Oral Communications 2: Diabetes 1
    Forum 2
    Chairs: Hubert Vidal (France) & Bruno Verges (France)
    12:00
    OC2.1
    EVERY FIFTH PATIENT WITH TYPE 1 DIABETES SUFFERS FROM AN ADDITIONAL ENDOCRINOLOGICAL AUTOIMMUNE DISEASE – A FINNISH NATIONWIDE STUDY
    Sari Mäkimattila
    12:12
    OC2.2
    Elevated glucose uptake in skeletal muscle with increased sarcolemma translocation of GLUT4 and glycogen synthesis contributes to bariatric surgery mediated diabetes remission
    Qiaoran Liu
    12:24
    OC2.3
    Identification of oxygen-18 isotope of breath carbon dioxide as a non-invasive marker to distinguish type 1 and type 2 diabetes
    Chiranjit Ghosh
    12:36
    OC2.4
    Empagliflozin attenuates the progression of atherosclerosis in APO-E knockout mice
    Narjes Nasiri-Ansari
    12:48
    OC2.5
    5β-reductase (AKR1D1) deletion drives hepatic inflammation, fibrosis and tumour development in vitro and in vivo
    Shelley Harris
    12:00 - 13:00 
    Oral Communications 3: Cushing's and acromegaly
    Forum 1
    Chairs: Ansgar Heck (Norway) & Marianne Andersen (Denmark)
    12:00
    OC3.1
    Osilodrostat provides clinical benefit over 48 weeks in patients with Cushing disease: Results from the LINC 3 study
    Rosario Pivonello
    12:12
    OC3.2
    Outcomes after primary treatment for Nelson’s syndrome: a study from 13 UK centres
    Athanasios Fountas
    12:24
    OC3.3
    Monosynaptic inputs to corticotropin-releasing hormone neuron in hypothalamic paraventricular nucleus of mice at the whole brain scale
    Jiang-Ning Zhou
    12:36
    OC3.4
    Restoration of basal glucose turnover after disease control in acromegaly depends on treatment modality: a prospective, investigator-initiated trial
    Mai Arlien-Søborg
    12:48
    OC3.5
    T2-signal intensity, SST receptor expression and first-generation somatostatin analogues efficacy predict hormone and tumor responses to pasireotide in acromegaly
    Eva Coopmans
    12:00 - 13:00 
    Oral Communications 4: Thyroid 2
    Forum 3
    Chairs: Bernard Goichot (France) & James Hennessey (USA)
    12:00
    OC4.1
    Subclinical hypothyroidism throughout pregnancy in TPOAb positive pregnant women
    Marta Astigarraga
    12:12
    OC4.2
    Thyroid Dysfunction And Mortality In Cardiovascular Hospitalized Patients – A 12 year Follow-up Observational Study
    Meir Frankel
    12:24
    OC4.3
    PROGNOSTIC IMPACT OF MICROSCOPIC EXTRATHYROIDAL EXTENSION (mETE) ON RECURRENCE-FREE SURVIVAL IN PATIENTS WITH PAPILLARY THYROID CARCINOMA (PTC)
    Nadia Bouzehouane
    12:36
    OC4.4
    Cardiac and vascular characteristics of thyroid hormone resistance syndrome in France
    Paul Sibilia
    12:48
    OC4.5
    A comprehensive assessment of the interplay between the thyroid function and the immune system: results from the Human Functional Genomics Project
    Romana Netea-Maier
    13:00 - 15:00 
    Lunch & Poster viewing
    Exhibition area
    13:00 - 13:45 
    Nurses Textbook Launch, Lunch and Informal Networking
    ECE Hub
    13:45 - 14:45 
    Industry Sponsored Satellite Symposium
    Forum 2
    13:45 - 14:45 
    Industry Sponsored Satellite Symposium
    Forum 1
    13:45 - 14:45 
    Industry Sponsored Satellite Symposium
    Salle Gratte-Ciel 1+2+3
    14:00 - 14:45 
    New Scientific Approach 1
    Forum 3
    Chair: Matti Poutanen (Finland)
    14:00
    NSA1
    Steroidomics
    Stefan Wudy (Giessen, Germany)
    14:00 - 14:45 
    New Scientific Approach 2
    Auditorium Lumière
    Chair: Agnieszka Piekielko-Witkowska (Poland)
    14:00
    NSA2
    Single cell spatial reconstruction of endocrine organs
    Keren Halpern
    15:00 - 16:30 
    Symposium 6: A better life with thyroid hormone
    ENDORSED BY: EJE (European Journal of Endocrinology)
    L'Amphithéâtre
    Chairs: Emese Mezosi (Hungary) & Ulla Feldt-Rasmussen (Denmark)
    Thyroid
    15:00
    S6.1
    Prediction of the thyroid axis set-point
    Marco Medici
    15:30
    S6.2
    Subclinical hypothyroidism in children
    Maria Salerno
    16:00
    S6.3
    Subclinical hypothyroidism in the elderly
    Simon Pearce (Newcastle, UK)
    15:00 - 16:30 
    Symposium 7: Endocrine Disrupting Chemicals
    ENDORSED BY: EC (Endocrine Connections)
    Forum 3
    Chairs: Josef Koehrle (Germany) & Anne-Simone Parent (Belgium)
    Environmental, Society and Governance
    15:00
    S7.1
    Endocrine Disrupting Chemicals and Thyroid
    Jean Fini
    15:30
    S7.2
    Endocrine Disrupting Chemicals and Diabetes Mellitus
    Angel Nadal
    16:00
    S7.3
    Endocrine Disrupting Chemicals and Obesity
    Bruce Blumberg
    15:00 - 16:30 
    Symposium 8: Gender dysphoria
    Salle Gratte-Ciel 1+2+3
    Chairs: Feyza Darendeliler (Turkey) & Luca Persani (Italy)
    Interdisciplinary Endocrinology
    15:00
    S8.1
    Psychoendocrinology Of Gender Dysphoria
    Emmanuele Jannini
    15:30
    S8.2
    Gender Dysphoria –management of puberty
    Martine Cools (Gent, Belgium)
    16:00
    S8.3
    Gender reassignment surgery in dysphoria
    Nicolas Morel-Journel
    15:00 - 16:30 
    Symposium 9: Controversies in adrenal disease
    Forum 2
    Chairs: Judith Favier (France) & Daniel Olsson (Sweden)
    Adrenal and Neuroendocrine Tumours
    15:00
    S9.3
    Is there a role for subtotal adrenalectomy
    Radu Mihai
    15:30
    S9.1
    Metanephrines - plasma or urine?
    Graeme Eisenhofer
    16:00
    S9.2
    The do's and don'ts of genetic testing in phaeochromocytoma
    Mercedes Robledo
    15:00 - 16:30 
    Symposium 10: Cancer drug-induced osteoporosis
    ENDORSED BY: EC (Endocrine Connections)
    Forum 1
    Chairs: Martine Cohen-Solal (France) & Carola Zillikens (The Netherlands)
    Calcium and Bone
    15:00
    S10.1
    Mechanisms of skeletal metastasis (could be induced by breast cancer or prostate cancer or both)
    Martina Rauner (Dresden, Germany)
    15:30
    S10.2
    Aromatase inhibitors and bone
    Carola Zillikens
    16:00
    S10.3
    TSH-suppressive therapy and bone
    Claudio Marcocci
    15:00 - 17:00 
    Nurses Session 3: Professional Development
    Salon Prestige Gratte-Ciel
    Chairs: Sofia Llahana (UK) & Sherwin Criseno (UK)
    15:00
    NPD1.1
    Update from the ESE Nurses Working Group, future projects and presentation of Poster Awards
    Sofia Llahana (London, UK)
    15:30
    NPD1.2
    2018 Poster Award Presentation: Testosterone replacement: 'The best practice' and the role of the Endocrine Nurse
    Anna Hawkins
    15:45
    NPD1.5
    Parallel Workshops - How to use the Textbook in Advanced Endocrine Nursing and Competency Framework to develop your clinical practice (Acromegaly)
    Chris Yedinak (USA), Lisa Shepherd)
    15:45
    NDP1.4
    Parallel Workshops - MY DIABBY – Improving skills and competence in diabetes education
    Houaria Chanson
    15:45
    NPD1.3
    Parallel Workshops - How to use the Textbook in Advanced Endocrine Nursing and Competency Framework to develop your clinical practice (Adrenal Insufficiency)
    Sofia Llahana (London, UK)
    15:15 - 16:30 
    Debate 1: Surgical treatment of phaeochromocytoma - query pre-treatment?
    Auditorium Lumière
    Chairs: Massimo Mannelli (Italy) & Frederic Castinetti (France)
    Adrenal and Neuroendocrine Tumours
    15:15
    D1.1
    FOR: Surgical treatment of phaeochromocytoma - query pre-treatment?
    Henri Timmers (Nijmegen, The Netherlands)
    15:15
    D1.2
    AGAINST: Surgical treatment of phaeochromocytoma - query pre-treatment?
    Martin Walz (Essen, Germany)
    16:30 - 17:00 
    Tea & Coffee
    Exhibition area
    17:00 - 17:30 
    Plenary 3
    L'Amphithéâtre
    Chairs: Bulent Yildiz (Turkey) & Anton Luger (Austria)
    17:00
    PL3
    Pancreatic beta-cell ageing: Novel mechanisms and consequences in the management of diabetes
    Susan Bonner-Weir
    17:45 - 19:15 
    Industry Sponsored Satellite Symposium
    Forum 1
    17:45 - 19:15 
    Industry Sponsored Satellite Symposium
    Forum 2
    17:45 - 19:15 
    Industry Sponsored Satellite Symposium
    Salle Gratte-Ciel 1+2+3
    19:30 - 23:00 
    Informal Networking Evening
    (Badge holders only)
Monday 20 May 41 sessions
    07:00 - 18:00 
    REGISTRATION
    08:00 - 08:40 
    Meet The Expert 6: Calcium and Bone
    Forum 3
    Calcium and Bone
    08:00
    MTE6
    Primary Hyperparathyroidism: Surgical vs Medical Therapy
    Tomaz Kocjan
    08:00 - 08:40 
    Meet The Expert 7: Pituitary and Neuroendocrinology
    L'Amphithéâtre
    Pituitary and Neuroendocrinology
    08:00
    MTE7
    Non functional Pituitary Tumours - not always easy
    Davide Carvalho
    08:00 - 08:40 
    Meet The Expert 8: Reproductive Endocrinology
    Auditorium Lumière
    Reproductive Endocrinology
    08:00
    MTE8
    Co-morbidities in Turner syndrome
    Claus Gravholt
    08:00 - 08:40 
    Meet The Expert 9: Reproductive Endocrinology
    Forum 2
    Reproductive Endocrinology
    08:00
    MTE9
    Co-morbidities in Klinefelter syndrome
    Anne Skakkebæk
    08:00 - 08:40 
    Meet The Expert 10: Reproductive Endocrinology
    Forum 1
    Reproductive Endocrinology
    08:00
    MTE10
    NCAH and Female reproduction
    Eda Ertorer
    08:00 - 08:40 
    Meet The Basic Scientist 2
    Salle Gratte-Ciel 1+2+3
    08:00
    MTBS2
    Genetically tailored pig models in translational endocrine and metabolic research
    Eckhard Wolf
    08:50 - 09:20 
    Plenary 4
    L'Amphithéâtre
    Chairs: Camilla Schalin-Jäntti (Finland) & Beata Kos-Kulda (Poland)
    08:50
    PL4
    Exercise training in the management of T2D
    Juleen Zierath
    09:20 - 09:50 
    Plenary: European Hormone Medal Lecture
    L'Amphithéâtre
    Chairs: Djuro Macut (Serbia) & Andrea Giustina (Italy)
    09:20
    EHM1
    Monogenic Bone Disorders as a Model for Novel Treatment of Osteoporosis
    Jens Bollerslev
    09:50 - 10:20 
    Tea & Coffee
    Exhibition area
    10:20 - 11:20 
    Debate 2: T4 is not enough
    L'Amphithéâtre
    Chairs: Robin Peeters (The Netherlands) & Patrice Rodien (France)
    Thyroid
    10:20
    D2.2
    AGAINST: No, T4 is enough
    James Hennessey
    10:20
    D2.1
    FOR: Yes, T4 is not enough
    Birte Nygaard
    10:20 - 11:50 
    Symposium 11: EDCs and reproduction
    Forum 3
    Chairs: Rachel Desailloud (France) & Anna-Maria Andersson (Denmark)
    Environmental, Society and Governance
    10:20
    S11.1
    Oocytes, Pesticides and IVF
    Moncef Benkhalifa
    10:50
    S11.2
    Testicular germ cell cancer: role of fœtal exposure to endocrine disruptors
    Patrick Fénichel
    11:20
    S11.3
    Mitigating against endocrine disruption in pregnancy
    Katharina Main
    10:20 - 11:50 
    Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
    Forum 1
    Chairs: Michael Buchfelder (Germany) & Cesar Boguszewski (Brazil)
    Pituitary and Neuroendocrinology
    10:20
    S12.1
    The view of the surgeon: When, how much and when to refrain from surgery?
    Stephanie Puget
    10:50
    S12.2
    New potential treatment alternatives in patients with papillary craniopharyngioma
    Tareq Juratli
    11:20
    S12.3
    How to manage the long-term consequences of hypothalamic damages
    Eva- Erfurth
    10:20 - 11:50 
    Symposium 13: Central Control of Metabolism: Brain rules all
    Salle Gratte-Ciel 1+2+3
    Chairs: Johannes Romijn (The Netherlands) & Ivana Kraljevic (Croatia)
    Diabetes, Obesity and Metabolism
    10:20
    S13.1
    All optics in the metabolic brain
    J. Betley
    10:50
    S13.2
    Role of mitochondria/cell bioenergetics in CNS regulation of energy balance
    Marc Claret
    11:20
    S13.3
    Genetics of appetite regulation
    Giles Yeo (Cambridge, UK)
    10:20 - 11:50 
    Symposium 14: Innovations in NETs
    Auditorium Lumière
    Chairs: Diego Ferone (Italy) & Mehtap Cakir (Turkey)
    Adrenal and Neuroendocrine Tumours
    10:20
    S14.1
    Innovative imaging of insulinoma: The end of sampling…
    Emanuel Christ
    10:50
    S14.2
    A role for radionuclide therapy for high-grade NETs
    Halfdan Sorbye
    11:20
    S14.3
    Fishing for NETs
    Giovanni Vitale
    10:20 - 11:50 
    Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
    Forum 2
    Chairs: Peter Aldiss (UK) & Thomas Cuny (France)
    Organ cross-talk in endocrine disease
    10:20
    S15.1
    Welcome and Introduction to EYES
    Peter Aldiss
    10:25
    S15.2
    Investigating glucocorticoids as the mechanism behind bone marrow adiposity expansion during caloric restriction
    Andrea Lovdel
    10:45
    S15.3
    Role of hypothalamic bile acid-TGR5 signaling in the regulation of energy balance
    Ashley Castellanos
    11:05
    S15.4
    The role and cross-talk between incretin hormones and occurrence of Nonalcoholic steatohepatitis
    Benjamin Bouillet
    11:25
    S15.5
    Lysophosphatidic acid in pathogenesis of HNF1B-MODY syndrome
    Beata Malachowska
    11:45
    S15.6
    Closing remarks
    Thomas Cuny
    10:20 - 12:05 
    Nurses Session 4: Parathyroid Disorders
    Salon Prestige Gratte-Ciel
    Chairs: Zaki Hassan-Smith (UK) & Maria Pedersen (Sweden)
    10:20
    NPD2.1
    Hypoparathyroidism: Aetiology, diagnosis and challenges in management
    Ansgar Heck
    10:55
    NPD2.2
    Hyperparathyroidism: Evidence-based screening and management
    Rachel Crowley (Dublin, Ireland)
    11:30
    NPD2.3
    Parathyroid Surgery: Indications and Consequences
    Jean Lifante
    12:00 - 13:00 
    Debate 3: Pituitary Pathology: Do we care?
    L'Amphithéâtre
    Chairs: Gerald Raverot (France) & Jens Otto Jorgensen (Denmark)
    Pituitary and Neuroendocrinology
    12:00
    D3.1
    FOR: Yes, we care about pituitary pathology
    Olivera Casar-Borota
    12:00
    D3.2
    AGAINST: No, we don't care about pituitary pathology
    Sven Schlaffer
    12:00 - 13:00 
    Oral Communications 8: Reproduction 1
    Forum 1
    Chairs: Victor Navarro (USA) & Nadine Binart (France)
    12:00
    OC8.1
    Dissecting the roles of KNDy-derived kisspeptins in the control of reproduction: Generation and characterization of the Tac2-specific Kiss1 KO (TaK-KO) mouse
    Delphine Franssen
    12:12
    OC8.2
    AMH is a predictive factor for successful sperm retrieval in non-mosaic Klinefelter syndrome patients
    Lucie Renault
    12:24
    OC8.3
    Endocrine Disruptors transgenerationally alters pubertal timing through epigenetic reprogramming of the hypothalamus.
    David Rodriguez
    12:36
    OC8.4
    Conditional ablation of AMP-Activated Protein Kinase (AMPK) in GnRH Neurons Reveals Specific Roles in Reproductive and Metabolic Homeostasis
    Juan Rivas
    12:48
    OC8.5
    The Neurokinin 3 Receptor Antagonist, Fezolinetant, Is Effective in Treatment of Menopausal Vasomotor Symptoms: Responder Analysis Results From a Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study
    Graeme Fraser
    12:00 - 13:00 
    Oral Communications 9: Thyroid 1
    Auditorium Lumière
    Chairs: Clara Alvarez (Spain) & Patrice Rodien (France)
    12:00
    OC9.1
    3D mapping and in silico predictions of the DEHAL1 enzyme as a tool to discriminate pathogenic mutations from non-functional variants in hypothyroidism
    Jorge García-Giménez
    12:12
    OC9.2
    Direct evidence for disulfides in the mechanism of deiodinase 1
    Ulrich Schweizer
    12:24
    OC9.3
    Novel driver mutations in thyroid cancer recurrence
    Hannah Nieto (Birmingham, United Kingdom)
    12:36
    OC9.4
    Resistance to thyroid hormone alpha associated with early-onset severe NASH
    Valentina Pautasso
    12:48
    OC9.5
    Deciphering the origin of the sexually dimorphic thyrotropin secretion in mouse models.
    Yasmine Kemkem
    12:00 - 13:00 
    Oral Communications 5: Adrenal 2
    Forum 3
    Chairs: Francoise Borson Chazot (France) & Felix Beuschlein (Switzerland)
    12:00
    OC5.1
    Positive impact of genetic test on the management and outcome of patients with paraganglioma and/or pheochromocytoma
    Alexandre Buffet
    12:12
    OC5.2
    Pheochromocytoma aggressiveness induced by tumor microenvironment depends on the SDH subunit involved
    Elena Rapizzi
    12:24
    OC5.3
    SF3B1 as novel target for the treatment of multiple endocrine-related cancers
    Juan Jiménez-Vacas
    12:36
    OC5.4
    The splicing factor NOVA1 is overexpressed in pancreatic neuroendocrine tumors and related to increased aggressiveness and malignancy
    Sergio Pedraza-Arévalo
    12:48
    OC5.5
    Impact of adrenal insufficiency on patient-centred health care outcomes in adult medical inpatients
    Andrea Widmer
    12:00 - 13:00 
    Oral Communications 6: Obesity 1
    Forum 2
    Chairs: Giles Yeo (UK) & Blandine Gatta-Cherifi (France)
    12:00
    OC6.1
    Impaired Glucose Homeostasis in Leptin-Deficient ob/ob Mice is Corrected by AZP-3404, a 9-Amino Acid Peptide Analog Derived from Insulin-Like Growth Factor-Binding Protein 2, a Key Mediator of Leptin Action
    Michael Culler
    12:12
    OC6.2
    Deep Transcranial Magnetic Stimulation modulates body temperature in obesity
    Anna Ferrulli
    12:24
    OC6.3
    Role of hypothalamic bile acid-TGR5 signaling in the regulation of energy balance
    Ashley Castellanos
    12:36
    OC6.4
    Fat mass impact of Sirolimus after clinical islet transplantation, a case control study
    Arnaud Jannin
    12:48
    OC6.5
    Lipolysis Defect in White Adipose Tissue and Rapid Weight Regaining
    Michal Meron
    12:00 - 13:00 
    Oral Communications 7: Endocrine Connections
    Salle Gratte-Ciel 1+2+3
    Chairs: Corin Badiu (Romania) & Marie-Christine Vantyghem (France)
    12:00
    OC7.1
    Cortisol suppression or peripheral sensitivity and activation are associated with diabetes, hypertension and fragility fractures in postmenopausal eucortisolemic women
    Carmen Aresta
    12:12
    OC7.2
    Thyroid hormones are new key regulators of glucocorticoid metabolism
    Laura Bessiène
    12:24
    OC7.3
    HIGHER DOSE OF BUROSUMAB IS NEEDED FOR TREATMENT OF CHILDREN WITH SEVER FORMS OF X-LINKED HYPOPHOSPHATEMIA
    Volha Zhukouskaya
    12:36
    OC7.4
    Non-invasive detection of GNAS mutations causing McCune-Albright Syndrome with ddPCR on whole blood or circulating DNA.
    Anne Barlier
    12:48
    OC7.5
    Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) syndrome : French prospective study in a cohort of 25 patients
    Linda Humbert
    13:00 - 15:00 
    Lunch & Poster viewing
    Exhibition area
    13:00 - 14:00 
    ESE President meets new members
    13:00 - 14:00 
    Nurses Poster Viewing and Presentations, Lunch and Informal Networking
    Salon Prestige Gratte-Ciel
    13:00 - 13:45 
    Endo-ERN Session - Lunch Hub
    ECE Hub
    13:00
    ERN1.1
    Introduction and update on Endo-ERN
    Alberto Arias
    13:01
    ERN1.2
    Core activities of Endo-ERN in close collaboration with ESE and ESPE: the multi-disciplinary approach
    Lars Rejnmark
    13:02
    ERN1.3
    Core activities of Endo-ERN in close collaboration with ESE and ESPE: the multi-disciplinary approach
    Danielle Steenvoorden
    13:45 - 14:45 
    Industry Sponsored Satellite Symposium
    Forum 2
    13:45 - 14:45 
    Industry Sponsored Satellite Symposium
    Forum 3
    13:45 - 14:45 
    Industry Sponsored Satellite Symposium
    Auditorium Lumière
    14:00 - 14:45 
    New Scientific Approach 3
    Salle Gratte-Ciel 1+2+3
    Chair: Guillaume Assie (France)
    14:00
    NSA3
    Intelligent image based in situ single cell isolation
    Gabor Tamas
    14:00 - 14:45 
    New Scientific Approach 4
    Forum 1
    Chair: Vera Popovic (Serbia)
    14:00
    NSA4
    When will AI take over from the endocrinologist?
    Anca Bucur
    15:00 - 16:30 
    Symposium 16: Thyroid in pregnancy
    L'Amphithéâtre
    Chairs: Sophie Christin-Maitre (France) & Leonidas Duntas (Greece)
    Thyroid
    15:00
    S16.1
    Thyroid autoimmunity and fertility
    David Unuane
    15:30
    S16.2
    Thyroid disease and pregnancy outcomes
    Fereidoun Azizi
    16:00
    S16.3
    Thyroid disease and offspring development
    Deborah Levie
    15:00 - 16:30 
    Symposium 17: Where Do Pituitary Tumours Come From
    Forum 1
    Chairs: Günter K. Stalla (Germany) & Philippe Chanson (France)
    Pituitary and Neuroendocrinology
    15:00
    S17.1
    Specification of cell fate
    Jacques Drouin
    15:30
    S17.2
    Pertubations in novel signalling pathways
    Cynthia Andoniadou (London, UK)
    16:00
    S17.3
    From Lab to Clinic - Can we translate into effective therapeutics
    Peter Kamenicky
    15:00 - 16:30 
    Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
    Salle Gratte-Ciel 1+2+3
    Chairs: Ursula Kaiser (USA) & Nelly Pitteloud (Switzerland)
    Reproductive Endocrinology
    15:00
    S18.1
    GnRH migration and vomeronasal neurons
    Paolo Forni
    15:30
    S18.2
    Flipping the GnRH switch with microRNAs
    Andrea Messina
    16:00
    S18.3
    Congenital Hypogonadotropic Hypogonadism: Clinical Perspectives
    Jacques Young
    15:00 - 16:30 
    Symposium 19: Adrenal Insufficiency
    Forum 2
    Chairs: Antoine Tabarin (France) & Thierry Brue (France)
    Adrenal and Neuroendocrine Tumours
    15:00
    S19.1
    New insights into autoimmune adrenal insufficiency
    Eystein Husebye
    15:30
    S19.2
    Long-term results of slow acting glucocorticoids - are they really better?
    Gudmundur Johannsson
    16:00
    S19.3
    Optimising care delivery in Congenital Adrenal Hyperplasia
    Nils Krone
    15:00 - 16:30 
    Symposium 20: News on Nutrition: When to eat what
    Forum 3
    Chairs: Bruno Verges (France) & Justo Castaño (Spain)
    Diabetes, Obesity and Metabolism
    15:00
    S20.1
    Precision Nutrition for managing obesity – Does it work?
    Carlos Celis-Morales
    15:30
    S20.2
    Is limiting the timing of food intake a viable nutritional approach?
    Denise Robertson
    16:00
    S20.3
    PREDIMED Plus trial - energy-restricted Mediterranean diet plus exercise and metabolic health
    Emilio Ros
    15:00 - 16:30 
    Guidelines Session: ESE Clinical Practice Guidelines on the Endocrine Work-up in Obesity
    Auditorium Lumière
    Chair: Michel Pugeat (France)
    15:00
    GS1
    Topics: 'Hormonal alterations in obesity', 'Thyroid dysfunction', 'Hypercortisolism', 'Gonadal dysfunction' & 'cther hormones'
    Renato Santini
    16:50 - 17:20 
    Plenary: Clinical Endocrinology Trust Lecture
    L'Amphithéâtre
    Chairs: Jerome Bertherat (France) & Wiebke Arlt (UK)
    16:50
    CET1
    How can patients perception of outcome be improved after controlling pituitary disease?
    Susan Webb (Barcelona, Spain)
    17:20 - 17:50 
    Plenary 5
    L'Amphithéâtre
    Chairs: Felix Beuschlein (Germany) & Françoise Borson-Chazot (France)
    17:20
    PL5
    Paracrine regulation of the adrenal cortex
    Hervé Lefebvre
    18:00 - 19:30 
    Industry Sponsored Satellite Symposium
    Salle Gratte-Ciel 1+2+3
Tuesday 21 May 38 sessions
    07:00 - 17:30 
    REGISTRATION
    08:00 - 08:40 
    Meet The Expert 11: Calcium and Bone
    Forum 2
    Calcium and Bone
    08:00
    MTE11
    Shifting treatment paradigms in osteoporosis
    Nuria Guanabens
    08:00 - 08:40 
    Meet The Expert 12: Calcium and Bone
    Forum 1
    Calcium and Bone
    08:00
    MTE12
    Fracture risk prediction in benign and tumoral bone: new insights
    Cyrille Confavreux
    08:00 - 08:40 
    Meet The Expert 13: Interdisciplinary Endocrinology
    Forum 3
    Interdisciplinary Endocrinology
    08:00
    MTE13
    Flushing, blushing and sweating
    Pierre Bouloux
    08:00 - 08:40 
    Meet The Expert 14: Interdisciplinary Endocrinology
    Salle Gratte-Ciel 1+2+3
    Interdisciplinary Endocrinology
    08:00
    MTE14
    How multidisciplinary care and tailor-made transition save lives of young adults with Prader-Willi syndrome
    Laura Graaff
    08:00 - 08:40 
    Meet The Expert 15: Pituitary and Neuroendocrinology
    L'Amphithéâtre
    Pituitary and Neuroendocrinology
    08:00
    MTE15
    To what degree does hypopituitarism exist after TBI?
    Marianne Klose
    08:00 - 08:40 
    Meet The Expert 16: Interdisciplinary Endocrinology
    Auditorium Lumière
    Interdisciplinary Endocrinology
    08:00
    MTE16.2
    Is it all in your head or just in the lab?
    Martin Bidlingmaier
    08:00
    MTE16.1
    Is it all in your head or just in the lab?
    Julio Abucham
    08:00 - 08:40 
    Meet The Basic Scientist 3
    Salon Prestige Gratte-Ciel
    08:00
    MTBS3
    The “Gravitostat” – How does it relate to hormones?
    John-Olov Jansson
    08:50 - 09:20 
    Plenary 6
    L'Amphithéâtre
    Chairs: Claudio Marcocci (Italy) & Jacque Orgiazzi (France)
    08:50
    PL6
    Treatment strategies for Graves orbitopathy
    George Kahaly (Mianz, Germany)
    09:20 - 09:50 
    Tea & Coffee
    Exhibition area
    09:50 - 10:50 
    Debate 4: MicroRNAs as hormones?
    Salle Gratte-Ciel 1+2+3
    Chairs: Peter Igaz (Hungary) & Attila Patócs (Hungary)
    Interdisciplinary Endocrinology
    09:50
    D4.2
    AGAINST: MicroRNAs as hormones?
    Alberto Davalos
    09:50
    D4.1
    FOR: MicroRNAs and extracellular vesicles as hormones?
    Edit Buzás
    09:50 - 11:20 
    Symposium 21: Rare Bone Disorders
    Forum 2
    Chairs: Barbara Obermayer-Pietsch (Austria) & Lars Rejmark (Denmark)
    Calcium and Bone
    09:50
    S21.1
    Animal model of bone fragility
    Antonella Forlino
    10:20
    S21.2
    New perspectives on the treatment of skeletal dysplasia
    Valérie Cormier-Daire (Paris, France)
    10:50
    S21.3
    Osteogenesis imperfecta throughout life
    Kassim Javaid
    09:50 - 11:20 
    Symposium 22: The Pituitary As Metabolic Sensor
    Forum 1
    Chairs: Clara Alvarez (Spain) & Agnieszka Baranowska-Bik (Poland)
    Pituitary and Neuroendocrinology
    09:50
    S22.1
    Kiss1 as integrator of endocrine and metabolic function in the hypothalamic-pituitary axis
    Victor Navarro
    10:20
    S22.2
    How treatments with endocrine & metabolic drugs influence pituitary cell function?
    Giovanni Tulipano
    10:50
    S22.3
    Bidirectional interrelationship between growth hormone and metabolism
    Raul Luque
    09:50 - 11:20 
    Symposium 23: PCOS: Can we personalise treatment?
    Auditorium Lumière
    Chairs: Marija Pfeifer (Slovenia) & Terhi Piltonen (Finland)
    Reproductive Endocrinology
    09:50
    S23.1
    Gut brain axis
    María Insenser
    10:20
    S23.2
    Implicating androgen excess in metabolic disease in PCOS

    Unknown speaker

    10:50
    S23.3
    Treatment options in cardiometabolic PCOS phenotype
    Mojca Sever
    09:50 - 11:20 
    Symposium 24: What's new in the Adrenal Cortex?
    ENDORSED BY: EJE (European Journal of Endocrinology)
    Forum 3
    Chairs: Darko Kastelan (Croatia) & Marc Lombes (France)
    Adrenal and Neuroendocrine Tumours
    09:50
    S24.1
    New genes, new understanding, new therapy
    Guillaume Assie
    10:20
    S24.2
    Primary hyperaldosteronism: does our treatment work?
    Tracy Williams
    10:50
    S24.3
    Autonomous cortisol secretion has cardiovascular consequences
    Iacopo Chiodini
    09:50 - 11:20 
    Symposium 25: Late breaking
    L'Amphithéâtre
    Chairs: Sebastian Neggers (The Netherlands) & Manuel Tena-Sempere (Spain)
    09:50
    S25.1
    Liver Stress kinases – crossroad between obesity and liver cancer (Source paper: Nature 2019)
    Guadalupe Sabio
    10:20
    S25.2
    LT4 treatment and pregnancy outcomes in TPOab positive women: results of the TABLET Trial
    Rima Smith
    10:50
    S25.3
    Maternal smoking and high BMI disrupt thyroid gland development
    Panagiotis Filis
    09:50 - 11:20 
    Publishing Session
    Salon Prestige Gratte-Ciel
    Chair: Beata Kos-Kulda (Poland)
    09:50
    PS1.1
    Endocrine Connections - ‘Increase the visibility of your research: open access and more’
    Josef Koehrle
    10:20
    PS1.2
    EDM Case Reports - ‘Top tips for writing and submitting an article – an early career researcher’s perspective’
    Gesthimani Mintziori
    10:50
    PS1.3
    European Journal of Endocrinology - ‘Common methodological flaws and how to avoid them’
    Olaf Dekkers
    11:30 - 12:30 
    Oral Communications 10: Adrenal 1
    Forum 2
    Chairs: Attila Patocs (Hungary) & Jerome Bertherat (France)
    11:30
    OC10.1
    Steroid Metabolomics: A Rapid Computational Approach for Accurate Differentiation of Inborn Disorders of Steroidogenesis.
    Elizabeth Baranowski
    11:42
    OC10.2
    Glucocorticoid resistance patients exhibit defective cortisol metabolism, responsible for functional hypermineralocorticism
    Géraldine Vitellius
    11:54
    OC10.3
    Genetic predisposition to Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH): next generation sequencing ARMC5, NR3C1 (Glucocorticoid Receptor) and PDE11A4 (Phosphodiesterase 11) in 389 patients
    Anna Vaczlavik
    12:06
    OC10.4
    Cullin 3 is a partner of Armadillo Repeat Containing 5 (ARMC5), the product of the gene responsible for Primary Bilateral Macronodular Adrenal Hyperplasia
    Isadora Cavalcante
    12:18
    OC10.5
    Cyclin Dependent Kinase 4 as promising drug target in adrenocortical carcinoma
    Cristina Ronchi (Birmingham, United Kingdom)
    11:30 - 12:30 
    UEMS Session
    Forum 3
    Chairs: Maeve Durkan (Republic of Ireland) & Teri Brouwer (The Netherlands)
    11:30
    UEMS1.2
    Update on European Exam in Endocrinology
    Graham Roberts
    11:45
    UEMS1.1
    The role of UEMS in Europe and the distinct and independent but allied pathway with ESE
    Maeve Durkan
    12:00
    UEMS1.3
    The microenvironment of pituitary neuroendocrine tumors: focus on folliculostellate cells
    Mirela Ilie
    11:30 - 12:30 
    Oral Communications 11: Diabetes 2
    Auditorium Lumière
    Chairs: Philippe Moulin (France) & Colin Duncan (UK)
    11:30
    OC11.1
    Hormonal factors and type 2 diabetes risk in women: a 22 year follow-up study on more than 83 000 women from the E3N cohort study
    Sopio Tatulashvili
    11:42
    OC11.2
    Molecular Mechanisms Regulating Hepatic Sex Hormone-Binding Globulin Production. Clinical Implications in Human Diseases.
    David Selva
    11:54
    OC11.3
    Implications of circulating Meteorin-like (Metrnl) level in human subjects with type 2 diabetes
    Hye Chung
    12:06
    OC11.4
    MiR-30e-5p expression is downregulated in plasma and urine of type 1 diabetic patients with diabetic kidney disease
    Daisy Crispim
    12:18
    OC11.5
    Bone metabolism and circulating myeloid calcifying cells in diabetic post menopausal women: a case-control study
    Mariasara Persano
    11:30 - 12:30 
    Oral Communications 12: Endocrine Connections 2
    Salle Gratte-Ciel 1+2+3
    Chairs: Patric Delhanty (The Netherlands) & Paolo Beck-Peccoz (Italy)
    11:30
    OC12.1
    Weekly shifts in light-dark cycle disrupt circadian clock gene expression in bone and reduce bone turnover
    Elizabeth Winter
    11:42
    OC12.2
    Epigenetic Programming of Transgenerational Hypertension in Preterm Birth Mice
    Laurence Dumeige
    11:54
    OC12.3
    Neuronostatin and GPR107 system: a novel therapeutic circuit in Prostate Cancer.
    Prudencio Sáez-Martínez
    12:06
    OC12.4
    Long-term follow-up of antitumoral immunotherapy- induced hypophysitis in Lille hospital, France
    Emilie Merlen
    12:18
    OC12.5
    Sexual desire in transgender persons in relation with gender affirming hormone treatment. Results from ENIGI, a large multicenter prospective cohort study in transgender people
    Justine Defreyne
    11:30 - 12:30 
    Oral Communcations 13: Anteria and posteria pituitary
    Forum 1
    Chairs: Mirjam Christ-Crain (Sweden) & Charlotte Højby (Sweden)
    11:30
    OC13.1
    Arginine-stimulated Copeptin Measurements - A new Test for Diabetes Insipidus
    Bettina Winzeler
    11:42
    OC13.2
    Empagliflozin increases sodium-levels in patients with the syndrome of inappropriate antidiuretic hormone secretion – a randomized, double-blind, placebo-controlled trial
    Julie Refardt
    11:54
    OC13.3
    Pituitary tumour-derived chemokines modulate immune cell infiltrates in the tumour microenvironment leading to aggressive phenotype
    Pedro Marques
    12:06
    OC13.4
    Pharmacokinetics of somapacitan in individuals with hepatic impairment: an open-label, parallel group, phase 1 study
    Birgitte Damholt
    12:18
    OC13.5
    Pan-genomic classification of Pituitary Adenomas
    Mario Neou
    11:30 - 12:30 
    Oral Communications 14: Sex Hormones
    Salon Prestige Gratte-Ciel
    Chairs: Ilpo Huhtaniemi (Finland) & Michel Pugeat (France)
    11:30
    OC14.1
    Testosterone replacement therapy is able to reduce prostate inflammation in men with BPH, metabolic syndrome and hypogonadism: preliminary results from a randomized placebo-controlled clinical trial
    Giulia Rastrelli
    11:42
    OC14.2
    The effect of testosterone therapy on serum oestradiol levels in transgender men
    Justine Defreyne
    11:54
    OC14.3
    First identification of Bone Morphogenic Protein Receptor variants as a cause of Primary Ovarian Insufficiency
    Isabelle Beau
    12:06
    OC14.4
    Thyroid diseases in Danish women with polycystic ovary syndrome.
    Dorte Glintborg
    12:18
    OC14.5
    The pattern of cancer occurrence in Turner syndrome
    Claus Gravholt
    12:30 - 14:30 
    Lunch & Poster viewing
    Exhibition area
    12:45 - 13:30 
    ESE Annual General Meeting
    13:00 - 13:45 
    EU research funding - overview of opportunities and insights towards a successful application
    ECE HUB - Exhibition area
    Chairs: Felix Beuschlein (Switzerland) & Valerie Handweiler (France)
    Hub 1.6
    13:30 - 14:15 
    New Scientific Approach 5
    Forum 1
    Chair: Cristina Olarescu (Norway)
    13:30
    NSA5
    Genome-wide effects of vitamin D on chromatin
    Carsten Carlberg
    13:30 - 14:15 
    New Scientific Approach 6
    Forum 2
    Chair: Patrice Mollard (France)
    13:30
    NSA6
    Brain imaging in conscious mice
    Pauline Campos
    14:30 - 15:30 
    Debate 5: Should we treat young osteoporotic patients
    L'Amphithéâtre
    Chairs: Gesthimani Mintziori (Greece) & Carola Zillikens (The Netherlands)
    Calcium and Bone
    14:30
    D5.2
    AGAINST: No, we shouldn't treat young osteoporotic patients
    Barbara Obermayer-Pietsch
    14:30
    D5.1
    FOR: Yes, we should treat young osteoporotic patients
    Serge Ferrari
    14:30 - 16:00 
    Symposium 26: Impact of thyroid disease on...
    Auditorium Lumière
    Chairs: Marek Ruchala (Poland) & Leonidas Duntas (Greece)
    Thyroid
    14:30
    S26.1
    Role of thyroid hormones in the pathogenesis and treatment of psychiatric disorders
    Bernard Lerer
    15:00
    S26.2
    Bone
    Graham Williams
    15:30
    S26.3
    Cardiac hypertrophy
    Maria Barreto-Chaves
    14:30 - 16:00 
    Symposium 27: What's new in reproductive endocrinology?
    Forum 1
    Chairs: Jenny Visser (The Netherlands) & Sophie Christin-Maitre (France)
    Reproductive Endocrinology
    14:30
    S27.1
    Dissecting Androgens in PCOS
    Kirsty Walters
    15:00
    S27.2
    Large scale genetic studies in male infertility
    Frank Tuttelmann
    15:30
    S27.3
    Menopause and cardiovascular risk
    Irene Lambrinoudaki
    14:30 - 16:00 
    Symposium 28: Vitamin D - non-skeletal effects in RCTs
    Salle Gratte-Ciel 1+2+3
    Chairs: Bruno Lapauw (Belgium) & Nuria Guanabens (Spain)
    Calcium and Bone
    14:30
    S28.1
    Vitamin D and its metabolites
    Elisabeth Winter
    15:00
    S28.2
    Vitamin D and Type 1 Diabetes
    Suvi Virtanen
    15:30
    S28.3
    How and when to measure Vitamin D
    Jean Souberbielle
    14:30 - 16:00 
    Symposium 29: Endocrine controversies in sport
    Forum 2
    Chairs: Margaret Boguszewski (Brazil) & Martin Bidlingmaier (Germany)
    Environmental, Society and Governance
    14:30
    S29.1
    Female hyperandrogenism and elite sport
    Angelica Hirschberg (Stockholm, Sweden)
    15:00
    S29.2
    Performance enhancing drugs in young males
    Pim Ronde
    15:30
    S29.3
    Omics to fight doping
    Guan Wang
    14:30 - 16:00 
    Symposium 30: Personalised medicine in diabetes and obesity
    ENDORSED BY: EJE (European Journal of Endocrinology)
    Forum 3
    Chairs: Philippe Moulin (France) & Anneke van den Beukel (The Netherlands)
    Diabetes, Obesity and Metabolism
    14:30
    S30.1
    Mechanisms for Cardiovascular Complications of Diabetes – Implications for Personalized Therapy
    Dale Abel
    15:00
    S30.2
    New avenues for novel drugs to treat obesity
    John Wilding (Liverpool, United Kingdom)
    15:30
    S30.3
    Curing diabetes with alternatives: bariatric surgery
    Jochen Seufert
    16:00 - 16:30 
    Tea & Coffee
    Exhibition area
    16:30 - 17:00 
    ESE Young Investigator Awards and Jens Sandahl Christansen Awards Ceremony
    L'Amphithéâtre
    Chairs: Manuel Tena-Sempere (Spain) & Sebastian Neggers (The Netherlands) & Françoise Borson-Chazot (France)
    EYIJC1
    The metabolic effects of SGLT2 inhibitors – Does the increase in ketone bodies protect the heart?
    Esben Søndergaard
    EYIJC2
    Role of hypothalamic AMP-activated protein kinase (AMPK) in the central regulation of energy balance
    Miguel López
    17:00 - 17:30 
    Plenary 7
    L'Amphithéâtre
    Chairs: Riccarda Granata (Italy) & Daniela Cota (France)
    17:00
    PL7
    Diving into the brain basis of obesity/brain/periphery cross-talk in the regulation of peripheral metabolism
    Jens Brüning
    17:30 - 17:45 
    Closing Ceremony
    L'Amphithéâtre
Elena Rapizzi
Elena Rapizzi
OC5.2
Mon 20 12:00 Oral Communications 5: Adrenal 2
Pheochromocytoma aggressiveness induced by tumor microenvironment depends on the SDH subunit involved
Juan Jiménez-Vacas
Juan Jiménez-Vacas
OC5.3
Mon 20 12:00 Oral Communications 5: Adrenal 2
SF3B1 as novel target for the treatment of multiple endocrine-related cancers
Sergio Pedraza-Arévalo
Sergio Pedraza-Arévalo
OC5.4
Mon 20 12:00 Oral Communications 5: Adrenal 2
The splicing factor NOVA1 is overexpressed in pancreatic neuroendocrine tumors and related to increased aggressiveness and malignancy
Andrea Widmer
Andrea Widmer
OC5.5
Mon 20 12:00 Oral Communications 5: Adrenal 2
Impact of adrenal insufficiency on patient-centred health care outcomes in adult medical inpatients
Michael Culler
Michael Culler
OC6.1
Mon 20 12:00 Oral Communications 6: Obesity 1
Impaired Glucose Homeostasis in Leptin-Deficient ob/ob Mice is Corrected by AZP-3404, a 9-Amino Acid Peptide Analog Derived from Insulin-Like Growth Factor-Binding Protein 2, a Key Mediator of Leptin Action
Anna Ferrulli
Anna Ferrulli
OC6.2
Mon 20 12:00 Oral Communications 6: Obesity 1
Deep Transcranial Magnetic Stimulation modulates body temperature in obesity
Arnaud Jannin
Arnaud Jannin
OC6.4
Mon 20 12:00 Oral Communications 6: Obesity 1
Fat mass impact of Sirolimus after clinical islet transplantation, a case control study
Michal Meron
Michal Meron
OC6.5
Mon 20 12:00 Oral Communications 6: Obesity 1
Lipolysis Defect in White Adipose Tissue and Rapid Weight Regaining
Carmen Aresta
Carmen Aresta
OC7.1
Mon 20 12:00 Oral Communications 7: Endocrine Connections
Cortisol suppression or peripheral sensitivity and activation are associated with diabetes, hypertension and fragility fractures in postmenopausal eucortisolemic women
Laura Bessiène
Laura Bessiène
OC7.2
Mon 20 12:00 Oral Communications 7: Endocrine Connections
Thyroid hormones are new key regulators of glucocorticoid metabolism
Volha Zhukouskaya
Volha Zhukouskaya
OC7.3
Mon 20 12:00 Oral Communications 7: Endocrine Connections
HIGHER DOSE OF BUROSUMAB IS NEEDED FOR TREATMENT OF CHILDREN WITH SEVER FORMS OF X-LINKED HYPOPHOSPHATEMIA
Anne Barlier
Anne Barlier
OC7.4
Mon 20 12:00 Oral Communications 7: Endocrine Connections
Non-invasive detection of GNAS mutations causing McCune-Albright Syndrome with ddPCR on whole blood or circulating DNA.
Linda Humbert
Linda Humbert
OC7.5
Mon 20 12:00 Oral Communications 7: Endocrine Connections
Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) syndrome : French prospective study in a cohort of 25 patients
Alberto Arias
Alberto Arias
ERN1.1
Mon 20 13:00 Endo-ERN Session - Lunch Hub
Introduction and update on Endo-ERN
Lars Rejnmark
Lars Rejnmark
ERN1.2
Mon 20 13:00 Endo-ERN Session - Lunch Hub
Core activities of Endo-ERN in close collaboration with ESE and ESPE: the multi-disciplinary approach
Danielle Steenvoorden
Danielle Steenvoorden
ERN1.3
Mon 20 13:00 Endo-ERN Session - Lunch Hub
Core activities of Endo-ERN in close collaboration with ESE and ESPE: the multi-disciplinary approach
Gabor Tamas
Gabor Tamas
NSA3
Mon 20 14:00 New Scientific Approach 3
Intelligent image based in situ single cell isolation
Anca Bucur
Anca Bucur
NSA4
Mon 20 14:00 New Scientific Approach 4
When will AI take over from the endocrinologist?
David Unuane
David Unuane
S16.1
Mon 20 15:00 Symposium 16: Thyroid in pregnancy
Thyroid autoimmunity and fertility
Fereidoun Azizi
Fereidoun Azizi
S16.2
Mon 20 15:00 Symposium 16: Thyroid in pregnancy
Thyroid disease and pregnancy outcomes
Deborah Levie
Deborah Levie
S16.3
Mon 20 15:00 Symposium 16: Thyroid in pregnancy
Thyroid disease and offspring development
Jacques Drouin
Jacques Drouin
S17.1
Mon 20 15:00 Symposium 17: Where Do Pituitary Tumours Come From
Specification of cell fate
Dr Cynthia Andoniadou
Cynthia Andoniadou
S17.2
Mon 20 15:00 Symposium 17: Where Do Pituitary Tumours Come From
Pertubations in novel signalling pathways
Peter Kamenicky
Peter Kamenicky
S17.3
Mon 20 15:00 Symposium 17: Where Do Pituitary Tumours Come From
From Lab to Clinic - Can we translate into effective therapeutics
Paolo Forni
Paolo Forni
S18.1
Mon 20 15:00 Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
GnRH migration and vomeronasal neurons
Andrea Messina
Andrea Messina
S18.2
Mon 20 15:00 Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
Flipping the GnRH switch with microRNAs
Jacques Young
Jacques Young
S18.3
Mon 20 15:00 Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
Congenital Hypogonadotropic Hypogonadism: Clinical Perspectives
Eystein Husebye
Eystein Husebye
S19.1
Mon 20 15:00 Symposium 19: Adrenal Insufficiency
New insights into autoimmune adrenal insufficiency
Gudmundur Johannsson
Gudmundur Johannsson
S19.2
Mon 20 15:00 Symposium 19: Adrenal Insufficiency
Long-term results of slow acting glucocorticoids - are they really better?
Carlos Celis-Morales
Carlos Celis-Morales
S20.1
Mon 20 15:00 Symposium 20: News on Nutrition: When to eat what
Precision Nutrition for managing obesity – Does it work?
Denise Robertson
Denise Robertson
S20.2
Mon 20 15:00 Symposium 20: News on Nutrition: When to eat what
Is limiting the timing of food intake a viable nutritional approach?
Emilio Ros
Emilio Ros
S20.3
Mon 20 15:00 Symposium 20: News on Nutrition: When to eat what
PREDIMED Plus trial - energy-restricted Mediterranean diet plus exercise and metabolic health
Renato Santini
Renato Santini
GS1
Mon 20 15:00 Guidelines Session: ESE Clinical Practice Guidelines on the Endocrine Work-up in Obesity
Topics: 'Hormonal alterations in obesity', 'Thyroid dysfunction', 'Hypercortisolism', 'Gonadal dysfunction' & 'cther hormones'
Susan Webb
Susan Webb
CET1
Mon 20 16:50 Plenary: Clinical Endocrinology Trust Lecture
How can patients perception of outcome be improved after controlling pituitary disease?
Hervé Lefebvre
Hervé Lefebvre
PL5
Mon 20 17:20 Plenary 5
Paracrine regulation of the adrenal cortex
Nuria Guanabens
Nuria Guanabens
MTE11
Tue 21 08:00 Meet The Expert 11: Calcium and Bone
Shifting treatment paradigms in osteoporosis
Cyrille Confavreux
Cyrille Confavreux
MTE12
Tue 21 08:00 Meet The Expert 12: Calcium and Bone
Fracture risk prediction in benign and tumoral bone: new insights
Laura Graaff
Laura Graaff
MTE14
Tue 21 08:00 Meet The Expert 14: Interdisciplinary Endocrinology
How multidisciplinary care and tailor-made transition save lives of young adults with Prader-Willi syndrome
Marianne Klose
Marianne Klose
MTE15
Tue 21 08:00 Meet The Expert 15: Pituitary and Neuroendocrinology
To what degree does hypopituitarism exist after TBI?
Martin Bidlingmaier
Martin Bidlingmaier
MTE16.2
Tue 21 08:00 Meet The Expert 16: Interdisciplinary Endocrinology
Is it all in your head or just in the lab?
Julio Abucham
Julio Abucham
MTE16.1
Tue 21 08:00 Meet The Expert 16: Interdisciplinary Endocrinology
Is it all in your head or just in the lab?
John-Olov Jansson
John-Olov Jansson
MTBS3
Tue 21 08:00 Meet The Basic Scientist 3
The “Gravitostat” – How does it relate to hormones?
Professor George Kahaly
George Kahaly
PL6
Tue 21 08:50 Plenary 6
Treatment strategies for Graves orbitopathy
Alberto Davalos
Alberto Davalos
D4.2
Tue 21 09:50 Debate 4: MicroRNAs as hormones?
AGAINST: MicroRNAs as hormones?
Edit Buzás
Edit Buzás
D4.1
Tue 21 09:50 Debate 4: MicroRNAs as hormones?
FOR: MicroRNAs and extracellular vesicles as hormones?
Antonella Forlino
Antonella Forlino
S21.1
Tue 21 09:50 Symposium 21: Rare Bone Disorders
Animal model of bone fragility
Valérie Cormier-Daire
Valérie Cormier-Daire
S21.2
Tue 21 09:50 Symposium 21: Rare Bone Disorders
New perspectives on the treatment of skeletal dysplasia
Victor Navarro
Victor Navarro
S22.1
Tue 21 09:50 Symposium 22: The Pituitary As Metabolic Sensor
Kiss1 as integrator of endocrine and metabolic function in the hypothalamic-pituitary axis
Giovanni Tulipano
Giovanni Tulipano
S22.2
Tue 21 09:50 Symposium 22: The Pituitary As Metabolic Sensor
How treatments with endocrine & metabolic drugs influence pituitary cell function?
Raul Luque
Raul Luque
S22.3
Tue 21 09:50 Symposium 22: The Pituitary As Metabolic Sensor
Bidirectional interrelationship between growth hormone and metabolism
María Insenser
María Insenser
S23.1
Tue 21 09:50 Symposium 23: PCOS: Can we personalise treatment?
Gut brain axis
Mojca Sever
Mojca Sever
S23.3
Tue 21 09:50 Symposium 23: PCOS: Can we personalise treatment?
Treatment options in cardiometabolic PCOS phenotype
Guillaume Assie
Guillaume Assie
S24.1
Tue 21 09:50 Symposium 24: What's new in the Adrenal Cortex?
New genes, new understanding, new therapy
Tracy Williams
Tracy Williams
S24.2
Tue 21 09:50 Symposium 24: What's new in the Adrenal Cortex?
Primary hyperaldosteronism: does our treatment work?
Iacopo Chiodini
Iacopo Chiodini
S24.3
Tue 21 09:50 Symposium 24: What's new in the Adrenal Cortex?
Autonomous cortisol secretion has cardiovascular consequences
Guadalupe Sabio
Guadalupe Sabio
S25.1
Tue 21 09:50 Symposium 25: Late breaking
Liver Stress kinases – crossroad between obesity and liver cancer (Source paper: Nature 2019)
Rima Smith
Rima Smith
S25.2
Tue 21 09:50 Symposium 25: Late breaking
LT4 treatment and pregnancy outcomes in TPOab positive women: results of the TABLET Trial
Panagiotis Filis
Panagiotis Filis
S25.3
Tue 21 09:50 Symposium 25: Late breaking
Maternal smoking and high BMI disrupt thyroid gland development
Josef Koehrle
Josef Koehrle
PS1.1
Tue 21 09:50 Publishing Session
Endocrine Connections - ‘Increase the visibility of your research: open access and more’
Gesthimani Mintziori
Gesthimani Mintziori
PS1.2
Tue 21 09:50 Publishing Session
EDM Case Reports - ‘Top tips for writing and submitting an article – an early career researcher’s perspective’
Olaf Dekkers
Olaf Dekkers
PS1.3
Tue 21 09:50 Publishing Session
European Journal of Endocrinology - ‘Common methodological flaws and how to avoid them’
Elizabeth Baranowski
Elizabeth Baranowski
OC10.1
Tue 21 11:30 Oral Communications 10: Adrenal 1
Steroid Metabolomics: A Rapid Computational Approach for Accurate Differentiation of Inborn Disorders of Steroidogenesis.
Géraldine Vitellius
Géraldine Vitellius
OC10.2
Tue 21 11:30 Oral Communications 10: Adrenal 1
Glucocorticoid resistance patients exhibit defective cortisol metabolism, responsible for functional hypermineralocorticism
Anna Vaczlavik
Anna Vaczlavik
OC10.3
Tue 21 11:30 Oral Communications 10: Adrenal 1
Genetic predisposition to Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH): next generation sequencing ARMC5, NR3C1 (Glucocorticoid Receptor) and PDE11A4 (Phosphodiesterase 11) in 389 patients
Isadora Cavalcante
Isadora Cavalcante
OC10.4
Tue 21 11:30 Oral Communications 10: Adrenal 1
Cullin 3 is a partner of Armadillo Repeat Containing 5 (ARMC5), the product of the gene responsible for Primary Bilateral Macronodular Adrenal Hyperplasia
Graham Roberts
Graham Roberts
UEMS1.2
Tue 21 11:30 UEMS Session
Update on European Exam in Endocrinology
Maeve Durkan
Maeve Durkan
UEMS1.1
Tue 21 11:30 UEMS Session
The role of UEMS in Europe and the distinct and independent but allied pathway with ESE
Mirela Ilie
Mirela Ilie
UEMS1.3
Tue 21 11:30 UEMS Session
The microenvironment of pituitary neuroendocrine tumors: focus on folliculostellate cells
Sopio Tatulashvili
Sopio Tatulashvili
OC11.1
Tue 21 11:30 Oral Communications 11: Diabetes 2
Hormonal factors and type 2 diabetes risk in women: a 22 year follow-up study on more than 83 000 women from the E3N cohort study
David Selva
David Selva
OC11.2
Tue 21 11:30 Oral Communications 11: Diabetes 2
Molecular Mechanisms Regulating Hepatic Sex Hormone-Binding Globulin Production. Clinical Implications in Human Diseases.
Hye Chung
Hye Chung
OC11.3
Tue 21 11:30 Oral Communications 11: Diabetes 2
Implications of circulating Meteorin-like (Metrnl) level in human subjects with type 2 diabetes
Daisy Crispim
Daisy Crispim
OC11.4
Tue 21 11:30 Oral Communications 11: Diabetes 2
MiR-30e-5p expression is downregulated in plasma and urine of type 1 diabetic patients with diabetic kidney disease
Mariasara Persano
Mariasara Persano
OC11.5
Tue 21 11:30 Oral Communications 11: Diabetes 2
Bone metabolism and circulating myeloid calcifying cells in diabetic post menopausal women: a case-control study
Elizabeth Winter
Elizabeth Winter
OC12.1
Tue 21 11:30 Oral Communications 12: Endocrine Connections 2
Weekly shifts in light-dark cycle disrupt circadian clock gene expression in bone and reduce bone turnover
Laurence Dumeige
Laurence Dumeige
OC12.2
Tue 21 11:30 Oral Communications 12: Endocrine Connections 2
Epigenetic Programming of Transgenerational Hypertension in Preterm Birth Mice
Prudencio Sáez-Martínez
Prudencio Sáez-Martínez
OC12.3
Tue 21 11:30 Oral Communications 12: Endocrine Connections 2
Neuronostatin and GPR107 system: a novel therapeutic circuit in Prostate Cancer.
Emilie Merlen
Emilie Merlen
OC12.4
Tue 21 11:30 Oral Communications 12: Endocrine Connections 2
Long-term follow-up of antitumoral immunotherapy- induced hypophysitis in Lille hospital, France
Justine Defreyne
Justine Defreyne
OC12.5
Tue 21 11:30 Oral Communications 12: Endocrine Connections 2
Sexual desire in transgender persons in relation with gender affirming hormone treatment. Results from ENIGI, a large multicenter prospective cohort study in transgender people
Justine Defreyne
Justine Defreyne
OC14.2
Tue 21 11:30 Oral Communications 14: Sex Hormones
The effect of testosterone therapy on serum oestradiol levels in transgender men
Bettina Winzeler
Bettina Winzeler
OC13.1
Tue 21 11:30 Oral Communcations 13: Anteria and posteria pituitary
Arginine-stimulated Copeptin Measurements - A new Test for Diabetes Insipidus
Julie Refardt
Julie Refardt
OC13.2
Tue 21 11:30 Oral Communcations 13: Anteria and posteria pituitary
Empagliflozin increases sodium-levels in patients with the syndrome of inappropriate antidiuretic hormone secretion – a randomized, double-blind, placebo-controlled trial
Pedro Marques
Pedro Marques
OC13.3
Tue 21 11:30 Oral Communcations 13: Anteria and posteria pituitary
Pituitary tumour-derived chemokines modulate immune cell infiltrates in the tumour microenvironment leading to aggressive phenotype
Birgitte Damholt
Birgitte Damholt
OC13.4
Tue 21 11:30 Oral Communcations 13: Anteria and posteria pituitary
Pharmacokinetics of somapacitan in individuals with hepatic impairment: an open-label, parallel group, phase 1 study
Mario Neou
Mario Neou
OC13.5
Tue 21 11:30 Oral Communcations 13: Anteria and posteria pituitary
Pan-genomic classification of Pituitary Adenomas
Giulia Rastrelli
Giulia Rastrelli
OC14.1
Tue 21 11:30 Oral Communications 14: Sex Hormones
Testosterone replacement therapy is able to reduce prostate inflammation in men with BPH, metabolic syndrome and hypogonadism: preliminary results from a randomized placebo-controlled clinical trial
Isabelle Beau
Isabelle Beau
OC14.3
Tue 21 11:30 Oral Communications 14: Sex Hormones
First identification of Bone Morphogenic Protein Receptor variants as a cause of Primary Ovarian Insufficiency
Dorte Glintborg
Dorte Glintborg
OC14.4
Tue 21 11:30 Oral Communications 14: Sex Hormones
Thyroid diseases in Danish women with polycystic ovary syndrome.
Claus Gravholt
Claus Gravholt
OC14.5
Tue 21 11:30 Oral Communications 14: Sex Hormones
The pattern of cancer occurrence in Turner syndrome
Carsten Carlberg
Carsten Carlberg
NSA5
Tue 21 13:30 New Scientific Approach 5
Genome-wide effects of vitamin D on chromatin
Pauline Campos
Pauline Campos
NSA6
Tue 21 13:30 New Scientific Approach 6
Brain imaging in conscious mice
Barbara Obermayer-Pietsch
Barbara Obermayer-Pietsch
D5.2
Tue 21 14:30 Debate 5: Should we treat young osteoporotic patients
AGAINST: No, we shouldn't treat young osteoporotic patients
Serge Ferrari
Serge Ferrari
D5.1
Tue 21 14:30 Debate 5: Should we treat young osteoporotic patients
FOR: Yes, we should treat young osteoporotic patients
Bernard Lerer
Bernard Lerer
S26.1
Tue 21 14:30 Symposium 26: Impact of thyroid disease on...
Role of thyroid hormones in the pathogenesis and treatment of psychiatric disorders
Maria Barreto-Chaves
Maria Barreto-Chaves
S26.3
Tue 21 14:30 Symposium 26: Impact of thyroid disease on...
Cardiac hypertrophy
Kirsty Walters
Kirsty Walters
S27.1
Tue 21 14:30 Symposium 27: What's new in reproductive endocrinology?
Dissecting Androgens in PCOS
Frank Tuttelmann
Frank Tuttelmann
S27.2
Tue 21 14:30 Symposium 27: What's new in reproductive endocrinology?
Large scale genetic studies in male infertility
Irene Lambrinoudaki
Irene Lambrinoudaki
S27.3
Tue 21 14:30 Symposium 27: What's new in reproductive endocrinology?
Menopause and cardiovascular risk
Elisabeth Winter
Elisabeth Winter
S28.1
Tue 21 14:30 Symposium 28: Vitamin D - non-skeletal effects in RCTs
Vitamin D and its metabolites
Suvi Virtanen
Suvi Virtanen
S28.2
Tue 21 14:30 Symposium 28: Vitamin D - non-skeletal effects in RCTs
Vitamin D and Type 1 Diabetes
Jean Souberbielle
Jean Souberbielle
S28.3
Tue 21 14:30 Symposium 28: Vitamin D - non-skeletal effects in RCTs
How and when to measure Vitamin D
Pim Ronde
Pim Ronde
S29.2
Tue 21 14:30 Symposium 29: Endocrine controversies in sport
Performance enhancing drugs in young males
Guan Wang
Guan Wang
S29.3
Tue 21 14:30 Symposium 29: Endocrine controversies in sport
Omics to fight doping
Dale Abel
Dale Abel
S30.1
Tue 21 14:30 Symposium 30: Personalised medicine in diabetes and obesity
Mechanisms for Cardiovascular Complications of Diabetes – Implications for Personalized Therapy
Jochen Seufert
Jochen Seufert
S30.3
Tue 21 14:30 Symposium 30: Personalised medicine in diabetes and obesity
Curing diabetes with alternatives: bariatric surgery
Esben Søndergaard
Esben Søndergaard
EYIJC1
Tue 21 16:30 ESE Young Investigator Awards and Jens Sandahl Christansen Awards Ceremony
The metabolic effects of SGLT2 inhibitors – Does the increase in ketone bodies protect the heart?
Miguel López
Miguel López
EYIJC2
Tue 21 16:30 ESE Young Investigator Awards and Jens Sandahl Christansen Awards Ceremony
Role of hypothalamic AMP-activated protein kinase (AMPK) in the central regulation of energy balance
Jens Brüning
Jens Brüning
PL7
Tue 21 17:00 Plenary 7
Diving into the brain basis of obesity/brain/periphery cross-talk in the regulation of peripheral metabolism
Professor Mirjam Christ-Crain
Mirjam Christ-Crain
EJE1
Sat 18 18:20 Plenary: European Journal of Endocrinology Award Lecture
New approaches in the differential diagnosis of Diabetes insipidus
Professor John Wilding
John Wilding
S30.2
Tue 21 14:30 Symposium 30: Personalised medicine in diabetes and obesity
New avenues for novel drugs to treat obesity
Hannah Nieto
Hannah Nieto
OC9.3
Mon 20 12:00 Oral Communications 9: Thyroid 1
Novel driver mutations in thyroid cancer recurrence
Professor  Giles Yeo
Giles Yeo
S13.3
Mon 20 10:20 Symposium 13: Central Control of Metabolism: Brain rules all
Genetics of appetite regulation
Dr Rachel Crowley
Rachel Crowley
NPD2.2
Mon 20 10:20 Nurses Session 4: Parathyroid Disorders
Hyperparathyroidism: Evidence-based screening and management
Felix Beuschlein
Felix Beuschlein
PEM1.3
Sun 19 08:00 Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
The research view of Endocrinology in Europe
Nils Krone
Nils Krone
S19.3
Mon 20 15:00 Symposium 19: Adrenal Insufficiency
Optimising care delivery in Congenital Adrenal Hyperplasia
Dr Sasha Howard
Sasha Howard
S2.3
Sun 19 10:20 Symposium 2: Trends in Puberty
Genetic basis in puberty
Angelica Hirschberg
Angelica Hirschberg
S29.1
Tue 21 14:30 Symposium 29: Endocrine controversies in sport
Female hyperandrogenism and elite sport
Martine Cools
Martine Cools
S8.2
Sun 19 15:00 Symposium 8: Gender dysphoria
Gender Dysphoria –management of puberty
Ken Ong
Ken Ong
PL2
Sun 19 09:20 Plenary 2
Genetic epidemiology of puberty timing and reproductive lifespan
Professor Stefan Wudy
Stefan Wudy
NSA1
Sun 19 14:00 New Scientific Approach 1
Steroidomics
Professor Anne-Simone Parent
Anne-Simone Parent
S2.2
Sun 19 10:20 Symposium 2: Trends in Puberty
Endocrine disruptors in puberty
Kassim	 Javaid
Kassim Javaid
S21.3
Tue 21 09:50 Symposium 21: Rare Bone Disorders
Osteogenesis imperfecta throughout life
Dr Ruth Casey
Ruth Casey
OC1.1
Sun 19 12:00 Oral Communications 1: Calcium and Bone
Genetic testing for hereditary hyperparathyroidism in a large UK cohort
Dr Cristina Ronchi
Cristina Ronchi
OC10.5
Tue 21 11:30 Oral Communications 10: Adrenal 1
Cyclin Dependent Kinase 4 as promising drug target in adrenocortical carcinoma
Dr David Ray
David Ray
S3.1
Sun 19 10:20 Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
Circadian control of glucocorticoid function
Daniel Morganstein
Daniel Morganstein
NS1.2
Sun 19 10:20 Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
Immunotherapy-induced Endocrinopathies: Assessment, Management and Monitoring
Martin Schlumberger
Martin Schlumberger
S1.3
Sun 19 10:20 Symposium 1: Thyroid in cancer
New paradigms in the treatment of low risk thyroid cancer
Chris McCabe
Chris McCabe
S1.2
Sun 19 10:20 Symposium 1: Thyroid in cancer
Iodine refractoriness in thyroid cells
Pierre Bouloux
Pierre Bouloux
MTE13
Tue 21 08:00 Meet The Expert 13: Interdisciplinary Endocrinology
Flushing, blushing and sweating
Graham Williams
Graham Williams
S26.2
Tue 21 14:30 Symposium 26: Impact of thyroid disease on...
Bone
Günter Stalla
Günter Stalla
GH1
Sat 18 17:45 Plenary: Geoffrey Harris Award Lecture
Translational research in pituitary disease
Avi Friedman
Avi Friedman
PL1
Sat 18 19:00 Plenary 1
Designing Cities and Homes as Exercise Machines: Helping endocrinologists to fight metabolic disease
Christophe Block
Christophe Block
MTE1
Sun 19 08:00 Meet The Expert 1: Diabetes, Obesity and Metabolism
The road from flash and continuous glucose monitoring towards closed loop systems in diabetes
Roberto Vettor
Roberto Vettor
MTE2
Sun 19 08:00 Meet The Expert 2: Diabetes, Obesity and Metabolism
Long-term endocrine-metabolic effects of bariatric surgery: do the benefits really outweigh the risks?
Andrzej Januszewicz
Andrzej Januszewicz
MTE3
Sun 19 08:00 Meet The Expert 3: Adrenal and Neuroendocrine Tumours
The management of primary aldosteronism
Professor Nicole Reisch
Nicole Reisch
MTE4
Sun 19 08:00 Meet The Expert 4: Adrenal and Neuroendocrine Tumours
Management of a life-long disease in CAH
Laurence Leenhardt
Laurence Leenhardt
MTE5
Sun 19 08:00 Meet The Expert 5: Thyroid
Risk classification of thyroid nodules by ultrasound and indications for FNA
Lars Gormsen
Lars Gormsen
MTBS1
Sun 19 08:00 Meet The Basic Scientist 1: Interdisciplinary Endocrinology
New tracers for PET in humans and rodents: Hopes, aims and current evidence
Andrea Giustina
Andrea Giustina
PEM1.1
Sun 19 08:00 Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
Introduction: Why Policy and Advocacy matters, also to endocrinology - Includes methodology, response, demographics
Andrea Giustina
Andrea Giustina
PEM1.5
Sun 19 08:00 Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
Closing remarks and discussion
Jerome Bertherat
Jerome Bertherat
PEM1.2
Sun 19 08:00 Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
The clinical view of Endocrinology in Europe
Anneke Beukel
Anneke Beukel
PEM1.4
Sun 19 08:00 Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
The early-career perspective
Laura Fugazzola
Laura Fugazzola
S1.1
Sun 19 10:20 Symposium 1: Thyroid in cancer
What is the value of molecular markers in nodules
Alejandro Lomniczi
Alejandro Lomniczi
S2.1
Sun 19 10:20 Symposium 2: Trends in Puberty
Exploring the Epigenetic Landscape of Puberty
Andrea Isidori
Andrea Isidori
S3.2
Sun 19 10:20 Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
Fixing the Broken Clock in Adrenal Disorders
Takashi Yoshimura
Takashi Yoshimura
S3.3
Sun 19 10:20 Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
Light Up Your Sex Life!
Maria Stelmachowska-Banas
Maria Stelmachowska-Banas
S4.2
Sun 19 10:20 Symposium 4: Immunology and endocrinology
Clinical: Immunotherapy and endocrine disease
Olle Kämpe
Olle Kämpe
S4.3
Sun 19 10:20 Symposium 4: Immunology and endocrinology
Transitional: The diagnostic value of autoimmune antibodies in endocrine disorders
Patrizio Caturegli
Patrizio Caturegli
S4.1
Sun 19 10:20 Symposium 4: Immunology and endocrinology
Basic: Immunotherapy and endocrine disease
Hubert Vidal
Hubert Vidal
S5.1
Sun 19 10:20 Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
Human gut microbiome: hopes, threats and promises
Max Nieuwdorp
Max Nieuwdorp
S5.2
Sun 19 10:20 Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
Fecal transplantation: Myth or reality
Matthias Laudes
Matthias Laudes
S5.3
Sun 19 10:20 Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
Targeted Microbiome Intervention for handling insulin resistance
Jeff Holly
Jeff Holly
SS1.1
Sun 19 10:20 Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
Obesity gives you cancer: the bigger picture!
Erin Hanlon
Erin Hanlon
SS1.2
Sun 19 10:20 Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
Sleep Deficiency: A Pathway to Obesity
Felipe Casanueva
Felipe Casanueva
SS1.3
Sun 19 10:20 Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
Social economic impact of the globesity pandemic
Christelle Fouchardiere
Christelle Fouchardiere
NS1.1
Sun 19 10:20 Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
Overview of Immunotherapy: Indications and adverse effects
Mr Sherwin Criseno
Sherwin Criseno
NS1.3
Sun 19 10:20 Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
The Role of the Endocrine Nurse in Managing Patients with Immunotherapy-induced Endocrinopathies
Fernando Fernandez-Aranda
Fernando Fernandez-Aranda
C1.1
Sun 19 12:00 Controversies Session: Food addiction in humans: to be or not to be?
Food addiction in humans: to be or not to be?
Djuro Macut
Djuro Macut
ECAS1.1
Sun 19 12:00 ESE Council of Affiliated Societies Session
Mapping Endocrinology in Europe - ECAS report
George Mastorakos
George Mastorakos
ECAS1.2
Sun 19 12:00 ESE Council of Affiliated Societies Session
Centres of special interest - how could we move on?
Bulent Yildiz
Bulent Yildiz
ECAS1.3
Sun 19 12:00 ESE Council of Affiliated Societies Session
3rd Early Career Clinical Endocrinologist session at EndoBridge 2019 - referring of a patient from primary care to the endocrinology unit
Federica Saponaro
Federica Saponaro
OC1.2
Sun 19 12:00 Oral Communications 1: Calcium and Bone
Urinary magnesium as predictor of nephrolithiasis in patients with asymptomatic primary hyperparathyroidism
Sabrina Corbetta
Sabrina Corbetta
OC1.3
Sun 19 12:00 Oral Communications 1: Calcium and Bone
MENIN AND EZH2 ACTIVITIES MODULATE THE EXPRESSION OF THE LONG NON-CODING RNA HAR1B IN PARATHYROID TUMORS
Kristina Chen
Kristina Chen
OC1.4
Sun 19 12:00 Oral Communications 1: Calcium and Bone
Risk of Sepsis, Respiratory Infections, and Kidney or Other Genitourinary (GU) Infections in Patients with Chronic Hypoparathyroidism (HypoPT): A Retrospective Cohort Study
Heide Siggelkow
Heide Siggelkow
OC1.5
Sun 19 12:00 Oral Communications 1: Calcium and Bone
Renal Function in 711 patients with Hypoparathyroidism during more than 4 years of therapy
Ruth Northway
Ruth Northway
MTNE1
Sun 19 12:00 Nurses Session 2: Meet the Nurse Expert
Nursing Approach To The Holistic Care of Patients with Intellectual Disability
Sari Mäkimattila
Sari Mäkimattila
OC2.1
Sun 19 12:00 Oral Communications 2: Diabetes 1
EVERY FIFTH PATIENT WITH TYPE 1 DIABETES SUFFERS FROM AN ADDITIONAL ENDOCRINOLOGICAL AUTOIMMUNE DISEASE – A FINNISH NATIONWIDE STUDY
Qiaoran Liu
Qiaoran Liu
OC2.2
Sun 19 12:00 Oral Communications 2: Diabetes 1
Elevated glucose uptake in skeletal muscle with increased sarcolemma translocation of GLUT4 and glycogen synthesis contributes to bariatric surgery mediated diabetes remission
Chiranjit Ghosh
Chiranjit Ghosh
OC2.3
Sun 19 12:00 Oral Communications 2: Diabetes 1
Identification of oxygen-18 isotope of breath carbon dioxide as a non-invasive marker to distinguish type 1 and type 2 diabetes
Narjes Nasiri-Ansari
Narjes Nasiri-Ansari
OC2.4
Sun 19 12:00 Oral Communications 2: Diabetes 1
Empagliflozin attenuates the progression of atherosclerosis in APO-E knockout mice
Shelley Harris
Shelley Harris
OC2.5
Sun 19 12:00 Oral Communications 2: Diabetes 1
5β-reductase (AKR1D1) deletion drives hepatic inflammation, fibrosis and tumour development in vitro and in vivo
Rosario Pivonello
Rosario Pivonello
OC3.1
Sun 19 12:00 Oral Communications 3: Cushing's and acromegaly
Osilodrostat provides clinical benefit over 48 weeks in patients with Cushing disease: Results from the LINC 3 study
Athanasios Fountas
Athanasios Fountas
OC3.2
Sun 19 12:00 Oral Communications 3: Cushing's and acromegaly
Outcomes after primary treatment for Nelson’s syndrome: a study from 13 UK centres
Jiang-Ning Zhou
Jiang-Ning Zhou
OC3.3
Sun 19 12:00 Oral Communications 3: Cushing's and acromegaly
Monosynaptic inputs to corticotropin-releasing hormone neuron in hypothalamic paraventricular nucleus of mice at the whole brain scale
Mai Arlien-Søborg
Mai Arlien-Søborg
OC3.4
Sun 19 12:00 Oral Communications 3: Cushing's and acromegaly
Restoration of basal glucose turnover after disease control in acromegaly depends on treatment modality: a prospective, investigator-initiated trial
Eva Coopmans
Eva Coopmans
OC3.5
Sun 19 12:00 Oral Communications 3: Cushing's and acromegaly
T2-signal intensity, SST receptor expression and first-generation somatostatin analogues efficacy predict hormone and tumor responses to pasireotide in acromegaly
Marta Astigarraga
Marta Astigarraga
OC4.1
Sun 19 12:00 Oral Communications 4: Thyroid 2
Subclinical hypothyroidism throughout pregnancy in TPOAb positive pregnant women
Meir Frankel
Meir Frankel
OC4.2
Sun 19 12:00 Oral Communications 4: Thyroid 2
Thyroid Dysfunction And Mortality In Cardiovascular Hospitalized Patients – A 12 year Follow-up Observational Study
Nadia Bouzehouane
Nadia Bouzehouane
OC4.3
Sun 19 12:00 Oral Communications 4: Thyroid 2
PROGNOSTIC IMPACT OF MICROSCOPIC EXTRATHYROIDAL EXTENSION (mETE) ON RECURRENCE-FREE SURVIVAL IN PATIENTS WITH PAPILLARY THYROID CARCINOMA (PTC)
Paul Sibilia
Paul Sibilia
OC4.4
Sun 19 12:00 Oral Communications 4: Thyroid 2
Cardiac and vascular characteristics of thyroid hormone resistance syndrome in France
Romana Netea-Maier
Romana Netea-Maier
OC4.5
Sun 19 12:00 Oral Communications 4: Thyroid 2
A comprehensive assessment of the interplay between the thyroid function and the immune system: results from the Human Functional Genomics Project
Keren Halpern
Keren Halpern
NSA2
Sun 19 14:00 New Scientific Approach 2
Single cell spatial reconstruction of endocrine organs
Marco Medici
Marco Medici
S6.1
Sun 19 15:00 Symposium 6: A better life with thyroid hormone
Prediction of the thyroid axis set-point
Maria Salerno
Maria Salerno
S6.2
Sun 19 15:00 Symposium 6: A better life with thyroid hormone
Subclinical hypothyroidism in children
Professor Simon Pearce
Simon Pearce
S6.3
Sun 19 15:00 Symposium 6: A better life with thyroid hormone
Subclinical hypothyroidism in the elderly
Jean Fini
Jean Fini
S7.1
Sun 19 15:00 Symposium 7: Endocrine Disrupting Chemicals
Endocrine Disrupting Chemicals and Thyroid
Angel Nadal
Angel Nadal
S7.2
Sun 19 15:00 Symposium 7: Endocrine Disrupting Chemicals
Endocrine Disrupting Chemicals and Diabetes Mellitus
Bruce Blumberg
Bruce Blumberg
S7.3
Sun 19 15:00 Symposium 7: Endocrine Disrupting Chemicals
Endocrine Disrupting Chemicals and Obesity
Emmanuele Jannini
Emmanuele Jannini
S8.1
Sun 19 15:00 Symposium 8: Gender dysphoria
Psychoendocrinology Of Gender Dysphoria
Nicolas Morel-Journel
Nicolas Morel-Journel
S8.3
Sun 19 15:00 Symposium 8: Gender dysphoria
Gender reassignment surgery in dysphoria
Radu Mihai
Radu Mihai
S9.3
Sun 19 15:00 Symposium 9: Controversies in adrenal disease
Is there a role for subtotal adrenalectomy
Graeme Eisenhofer
Graeme Eisenhofer
S9.1
Sun 19 15:00 Symposium 9: Controversies in adrenal disease
Metanephrines - plasma or urine?
Mercedes Robledo
Mercedes Robledo
S9.2
Sun 19 15:00 Symposium 9: Controversies in adrenal disease
The do's and don'ts of genetic testing in phaeochromocytoma
Professor Martina Rauner
Martina Rauner
S10.1
Sun 19 15:00 Symposium 10: Cancer drug-induced osteoporosis
Mechanisms of skeletal metastasis (could be induced by breast cancer or prostate cancer or both)
Carola Zillikens
Carola Zillikens
S10.2
Sun 19 15:00 Symposium 10: Cancer drug-induced osteoporosis
Aromatase inhibitors and bone
Claudio Marcocci
Claudio Marcocci
S10.3
Sun 19 15:00 Symposium 10: Cancer drug-induced osteoporosis
TSH-suppressive therapy and bone
Dr Sofia Llahana
Sofia Llahana
NPD1.1
Sun 19 15:00 Nurses Session 3: Professional Development
Update from the ESE Nurses Working Group, future projects and presentation of Poster Awards
Dr Sofia Llahana
Sofia Llahana
NPD1.3
Sun 19 15:00 Nurses Session 3: Professional Development
Parallel Workshops - How to use the Textbook in Advanced Endocrine Nursing and Competency Framework to develop your clinical practice (Adrenal Insufficiency)
Anna Hawkins
Anna Hawkins
NPD1.2
Sun 19 15:00 Nurses Session 3: Professional Development
2018 Poster Award Presentation: Testosterone replacement: 'The best practice' and the role of the Endocrine Nurse
Chris Yedinak
Chris Yedinak
NPD1.5
Sun 19 15:00 Nurses Session 3: Professional Development
Parallel Workshops - How to use the Textbook in Advanced Endocrine Nursing and Competency Framework to develop your clinical practice (Acromegaly)
Houaria Chanson
Houaria Chanson
NDP1.4
Sun 19 15:00 Nurses Session 3: Professional Development
Parallel Workshops - MY DIABBY – Improving skills and competence in diabetes education
Dr Henri Timmers
Henri Timmers
D1.1
Sun 19 15:15 Debate 1: Surgical treatment of phaeochromocytoma - query pre-treatment?
FOR: Surgical treatment of phaeochromocytoma - query pre-treatment?
Professor Martin Walz
Martin Walz
D1.2
Sun 19 15:15 Debate 1: Surgical treatment of phaeochromocytoma - query pre-treatment?
AGAINST: Surgical treatment of phaeochromocytoma - query pre-treatment?
Susan Bonner-Weir
Susan Bonner-Weir
PL3
Sun 19 17:00 Plenary 3
Pancreatic beta-cell ageing: Novel mechanisms and consequences in the management of diabetes
Tomaz Kocjan
Tomaz Kocjan
MTE6
Mon 20 08:00 Meet The Expert 6: Calcium and Bone
Primary Hyperparathyroidism: Surgical vs Medical Therapy
Davide Carvalho
Davide Carvalho
MTE7
Mon 20 08:00 Meet The Expert 7: Pituitary and Neuroendocrinology
Non functional Pituitary Tumours - not always easy
Claus Gravholt
Claus Gravholt
MTE8
Mon 20 08:00 Meet The Expert 8: Reproductive Endocrinology
Co-morbidities in Turner syndrome
Anne Skakkebæk
Anne Skakkebæk
MTE9
Mon 20 08:00 Meet The Expert 9: Reproductive Endocrinology
Co-morbidities in Klinefelter syndrome
Eda Ertorer
Eda Ertorer
MTE10
Mon 20 08:00 Meet The Expert 10: Reproductive Endocrinology
NCAH and Female reproduction
Eckhard Wolf
Eckhard Wolf
MTBS2
Mon 20 08:00 Meet The Basic Scientist 2
Genetically tailored pig models in translational endocrine and metabolic research
Juleen Zierath
Juleen Zierath
PL4
Mon 20 08:50 Plenary 4
Exercise training in the management of T2D
Jens Bollerslev
Jens Bollerslev
EHM1
Mon 20 09:20 Plenary: European Hormone Medal Lecture
Monogenic Bone Disorders as a Model for Novel Treatment of Osteoporosis
James Hennessey
James Hennessey
D2.2
Mon 20 10:20 Debate 2: T4 is not enough
AGAINST: No, T4 is enough
Birte Nygaard
Birte Nygaard
D2.1
Mon 20 10:20 Debate 2: T4 is not enough
FOR: Yes, T4 is not enough
Moncef Benkhalifa
Moncef Benkhalifa
S11.1
Mon 20 10:20 Symposium 11: EDCs and reproduction
Oocytes, Pesticides and IVF
Patrick Fénichel
Patrick Fénichel
S11.2
Mon 20 10:20 Symposium 11: EDCs and reproduction
Testicular germ cell cancer: role of fœtal exposure to endocrine disruptors
Katharina Main
Katharina Main
S11.3
Mon 20 10:20 Symposium 11: EDCs and reproduction
Mitigating against endocrine disruption in pregnancy
Stephanie Puget
Stephanie Puget
S12.1
Mon 20 10:20 Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
The view of the surgeon: When, how much and when to refrain from surgery?
Tareq Juratli
Tareq Juratli
S12.2
Mon 20 10:20 Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
New potential treatment alternatives in patients with papillary craniopharyngioma
Eva- Erfurth
Eva- Erfurth
S12.3
Mon 20 10:20 Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
How to manage the long-term consequences of hypothalamic damages
J. Betley
J. Betley
S13.1
Mon 20 10:20 Symposium 13: Central Control of Metabolism: Brain rules all
All optics in the metabolic brain
Marc Claret
Marc Claret
S13.2
Mon 20 10:20 Symposium 13: Central Control of Metabolism: Brain rules all
Role of mitochondria/cell bioenergetics in CNS regulation of energy balance
Emanuel Christ
Emanuel Christ
S14.1
Mon 20 10:20 Symposium 14: Innovations in NETs
Innovative imaging of insulinoma: The end of sampling…
Halfdan Sorbye
Halfdan Sorbye
S14.2
Mon 20 10:20 Symposium 14: Innovations in NETs
A role for radionuclide therapy for high-grade NETs
Giovanni Vitale
Giovanni Vitale
S14.3
Mon 20 10:20 Symposium 14: Innovations in NETs
Fishing for NETs
Peter Aldiss
Peter Aldiss
S15.1
Mon 20 10:20 Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Welcome and Introduction to EYES
Andrea Lovdel
Andrea Lovdel
S15.2
Mon 20 10:20 Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Investigating glucocorticoids as the mechanism behind bone marrow adiposity expansion during caloric restriction
Ashley Castellanos
Ashley Castellanos
S15.3
Mon 20 10:20 Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Role of hypothalamic bile acid-TGR5 signaling in the regulation of energy balance
Ashley Castellanos
Ashley Castellanos
OC6.3
Mon 20 12:00 Oral Communications 6: Obesity 1
Role of hypothalamic bile acid-TGR5 signaling in the regulation of energy balance
Benjamin Bouillet
Benjamin Bouillet